According to the WHO, amongst all non-communicable diseases, cardiovascular disease (CVD) is the major cause of death in both developed and developing countries. In the year 2008, nearly 17 million people died of CVD around the globe, representing 30% death amongst all non-communicable diseases worldwide. The major chunk of death coming from the lower income […]
Epygen is pleased to announce opening of a state of art, Biotech incubation facility at Navi Mumbai, India. This consists of a full- fledged Bioprocessing Pilot facility, a Microbiology Laboratory and a Protein analysis division, suitable for evaluation and incubation of licensed Technologies to produce Therapeutic proteins and Enzymes of interest. A large scale Biotech […]
Epygen presented its technology on enzymatic kinetics at the World Congress on Industrial Biotechnology and Bioprocessing in Orlando, Florida. To use enzymatic bioconversion lots effectively, it is key to understand influences by range of parameters. This statistical model will be used infuture to develop artificial intelligence in maximizing enzymatic bioconversion. The topic was well received by […]
